Purchases and Sales Made in Q2 2023 in Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX) during Q2 2023. The information is specifically focused on institutions that hold shares of Gain Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
54.6K+ 359.99% |
$238K - $300K
|
69.8K
$125K
|
|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
44.5K+ 47.25% |
$194K - $245K
|
139K
$248K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
18.8K+ 107.75% |
$82K - $103K
|
36.2K
$64.9K
|
|
|
Jul 25, 2023
Q2 2023
|
Raymond James & Associates
St Petersburg, FL |
BUY
|
- |
13.4K+ 67.0% |
$58.4K - $73.7K
|
33.4K
$59.8K
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
12.6KNew |
$54.8K - $69.1K
|
12.6K
$22.5K
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
11.5K+ 21.89% |
$50.2K - $63.3K
|
64.1K
$115K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
8.9K+ 23.0% |
$38.8K - $49K
|
47.6K
$85.2K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
5.14K+ 119.44% |
$22.4K - $28.3K
|
9.45K
$16.9K
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
4.25K+ 17.14% |
$18.5K - $23.4K
|
29K
$52K
|
|
|
Aug 09, 2023
Q2 2023
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
2.36K+ 12.66% |
$10.3K - $13K
|
21K
$37.5K
|
|
|
Jul 17, 2023
Q2 2023
|
Hm Payson & CO
Portland, ME |
BUY
|
- |
1KNew |
$4.36K - $5.5K
|
1K
$1.79K
|
|
|
Aug 09, 2023
Q2 2023
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
847New |
$3.69K - $4.66K
|
847
$1.52K
|
|
|
Aug 14, 2023
Q2 2023
|
New Edge Advisors, LLC
New Orleans, LA |
BUY
|
- |
550+ 5.24% |
$2.4K - $3.03K
|
11.1K
$19.8K
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
6New |
$26.2 - $33
|
6
$10.7
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
5+ 0.13% |
$21.8 - $27.5
|
3.72K
$6.66K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.5K- 36.48% |
$10.9K - $13.7K
|
4.35K
$7.78K
|
|
|
Aug 14, 2023
Q2 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-13.9K- 23.17% |
$60.6K - $76.5K
|
46.1K
$82.5K
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-19K- 48.6% |
$82.6K - $104K
|
20K
$35.9K
|